2-(Dimethylamino)-ethanol tartrate | 29870-28-8

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物 - 无环羧酸
• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-(Dimethylamino)-ethanol tartrate
• 英文别名: 2,3-dihydroxybutanedioic acid;2-(dimethylamino)ethanol
• CAS: 29870-28-8
• 化学式: C8H17NO7
• 分子量: 239.22
• InChiKey: UIEGYKVRCKDVKQ-UHFFFAOYSA-N

物化性质

• 熔点：
  109-113 °C

计算性质

• 辛醇/水分配系数(LogP)：
  -2.58
• 重原子数：
  16
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  139
• 氢给体数：
  5
• 氢受体数：
  8

安全信息

• WGK Germany：
  2
• RTECS号：
  KK7175000
• 海关编码：
  2922509090

文献信息

• Anti-aging nutritional supplement
  申请人：——

  公开号：US20040001817A1

  公开（公告）日：2004-01-01

  An anti-aging nutritional supplement composition includes vitamins, minerals, an inflammatory process support, a blood sugar/insulin support, a botanical antioxidants, a methylating factor, a DNA repair agent, a fat metabolizer, an absorption enhancer, a brain function support, whole foods, a cellular energizer, a nucleotide precursor, amino acids, a fatty acid complex, and digestive enzymes. The composition supplies nutritional supplements necessary for proper glycation, DNA methylation, anti-oxidation, and control of inflammatory processes. The composition and the method of use provide an effective anti-aging treatment by decreasing DNA damage, increasing DNA repair, and improving immune function of human body.

  一种抗衰老营养补充剂组合包括维生素、矿物质、炎症过程支持、血糖/胰岛素支持、植物抗氧化剂、甲基化因子、DNA修复剂、脂肪代谢剂、吸收增强剂、脑功能支持、全食物、细胞能量增强剂、核苷酸前体、氨基酸、脂肪酸复合物和消化酶。该组合提供了必要的营养补充剂，以适当地进行糖基化、DNA甲基化、抗氧化和控制炎症过程。该组合和使用方法通过减少DNA损伤、增加DNA修复和改善人体免疫功能，提供了有效的抗衰老治疗。
• METHODS AND COMPOUNDS FOR TREATING RETINOL-RELATED DISEASES
  申请人：MATA Nathan L.

  公开号：US20090088435A1

  公开（公告）日：2009-04-02

  Compounds that reduce serum retinol levels are used to treat ophthalmic conditions associated with the overproduction of waste products that accumulate during the course of the visual cycle. We describe methods, compounds, and compositions to treat, for example, the macular degenerations and dystrophies or to alleviate symptoms associated with such ophthalmic conditions.

  降低血清视黄醇水平的化合物被用于治疗与视觉循环过程中积累的废物过度产生相关的眼科疾病。我们描述了处理黄斑变性和营养不良等疾病或缓解与此类眼科疾病相关症状的方法、化合物和组合物。
• Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders
  申请人：Milburn Michael

  公开号：US20060276393A1

  公开（公告）日：2006-12-07

  Provided herein are methods and compositions for treating or preventing neurodegenerative disorders or blood coagulation disorders. Methods may comprise modulating the activity or level of a sirtuin, such as SIRT1 or Sir2. Exemplary methods comprise contacting a cell with a sirtuin activating compound, such as a flavone, stilbene, flavanone, isoflavone, catechin, chalcone, tannin or anthocyanidin; or an inhibitory compound, such as nicotinamide.

  本文提供了治疗或预防神经退行性疾病或血液凝固疾病的方法和组合物。方法可以包括调节sirtuin的活性或水平，例如SIRT1或Sir2。示例方法包括使用sirtuin激活化合物（例如黄酮，苯乙烯，黄烷酮，异黄酮，儿茶素，查尔酮，单宁或花青素）或抑制化合物（例如烟酰胺）与细胞接触。
• Ionic Liquids
  申请人：Walker Adam John

  公开号：US20080221361A1

  公开（公告）日：2008-09-11

  The invention provides ionic liquids and processes for their preparation. The liquids may either comprise a cation of the formula (I); N + HR 1 R 2 R 3 (I) wherein R 1 is a group —R 4 —O—R 5 ; R 2 and R 3 are each independently either hydrogen or hydrocarbyl, R 2 and R 3 may be joined together with the N to form a heterocyclic group; R 4 is a divalent hydrocarbyl radical; and R 5 is hydrocarbyl; or a cation of the formula (II), N+HR6R7R8 (II) wherein R 6 is an alkanolyl group; R 7 is a hydrocarbyl group; and R 8 is either hydrogen or hydrocarbyl, or R 7 and R 8 may be joined together with the N to form a heterocyclic group.

  本发明提供了离子液体及其制备方法。这些液体可以包括公式（I）的阳离子; N+HR1R2R3（I），其中R1是一个基团-R4-O-R5; R2和R3分别是氢或烃基，R2和R3可以与N结合形成杂环基团; R4是一个二价的烃基基团; R5是烃基; 或者是公式（II）的阳离子，N+HR6R7R8（II），其中R6是烷基醇基团; R7是烃基基团; R8是氢或烃基，或者R7和R8可以与N结合形成杂环基团。
• COMPOSITIONS AND METHODS RELATING TO RESVERATROL
  申请人：Blanchard Otis L.

  公开号：US20150216982A1

  公开（公告）日：2015-08-06

  The present invention relates to compositions and methods comprising resveratrol and uses thereof. Some embodiments include compositions and methods with increased bioavailability of resveratrol. Certain embodiments include compositions comprising resveratrol and a solubilizer. Particular embodiments include transmucosal delivery of resveratrol from the composition.

  本发明涉及包含白藜芦醇的组合物和方法以及其用途。某些实施例包括具有增强的白藜芦醇生物利用度的组合物和方法。某些实施例包括包含白藜芦醇和溶解剂的组合物。特定实施例包括从该组合物中经黏膜递送白藜芦醇。

表征谱图